Online Inquiry
Inquiry

PAI-1

PAI-1

Plasminogen activation inhibitors (PAI) are divided into PAI-1 and PAl-2, among which PAI-1 plays a major role in regulating plasma fibrinolytic activity. PAI-1 is a 47,000 globular single-chain glycoprotein derived from the serine protease inhibitor superfamily and composed of 379 amino acid residues. The protein is synthesized in multiple tissues and cell types, such as liver, spleen, adipocytes, platelets, macrophages, smooth muscle cells, fibroblasts, tumor cells, and endothelial cells.

For more details about our plasminogen activation inhibitors-1, please click the links listed below.

  • UK-371804
  • CAT#:

    DMP-2312-LGZ-2

  • Application:

    uPA Inhibitor

  • CAS Number:

    256477-09-5

  • TM5441
  • CAT#:

    DMP-2312-LGZ-3

  • Application:

    PAI-1 Inhibitor

  • CAS Number:

    1190221-43-2

  • TM5275 Sodium
  • CAT#:

    DMP-2312-LGZ-4

  • Application:

    Plasminogen Activator Inhibitor

  • CAS Number:

    1103926-82-4

  • TM5007
  • CAT#:

    DMP-2312-LGZ-5

  • Application:

    PAI-1 Inhibitor

  • CAS Number:

    342595-05-5

Copyright © Protheragen. All rights reserves.